Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Dexmedetomidine Then Propofol	STARTED	Propofol First	5
Dexmedetomidine Then Propofol	STARTED	Dexmedetomidine First	6
Dexmedetomidine Then Propofol	COMPLETED	Propofol First	5
Dexmedetomidine Then Propofol	COMPLETED	Dexmedetomidine First	6
Dexmedetomidine Then Propofol	NOT COMPLETED	Propofol First	0
Dexmedetomidine Then Propofol	NOT COMPLETED	Dexmedetomidine First	0
Propofol Then Dexmedetomidine	STARTED	Propofol First	5
Propofol Then Dexmedetomidine	STARTED	Dexmedetomidine First	6
Propofol Then Dexmedetomidine	COMPLETED	Propofol First	5
Propofol Then Dexmedetomidine	COMPLETED	Dexmedetomidine First	6
Propofol Then Dexmedetomidine	NOT COMPLETED	Propofol First	0
Propofol Then Dexmedetomidine	NOT COMPLETED	Dexmedetomidine First	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01045122/flow